Meridian Bioscience Stock Market Capitalization
| VIVODelisted Stock | USD 33.97 0.00 0.00% |
Meridian Bioscience fundamentals help investors to digest information that contributes to Meridian Bioscience's financial success or failures. It also enables traders to predict the movement of Meridian Stock. The fundamental analysis module provides a way to measure Meridian Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Meridian Bioscience stock.
Meridian |
Meridian Bioscience Company Market Capitalization Analysis
Meridian Bioscience's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Meridian Bioscience Market Capitalization | 1.49 B |
Most of Meridian Bioscience's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Meridian Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Meridian Bioscience is about 1.49 B. This is 88.5% lower than that of the Health Care Equipment & Supplies sector and 79.71% lower than that of the Health Care industry. The market capitalization for all United States stocks is 92.18% higher than that of the company.
Meridian Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Meridian Bioscience's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Meridian Bioscience could also be used in its relative valuation, which is a method of valuing Meridian Bioscience by comparing valuation metrics of similar companies.Meridian Bioscience is currently under evaluation in market capitalization category among its peers.
Meridian Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 1.39 B | |||
| Shares Outstanding | 43.83 M | |||
| Shares Owned By Insiders | 1.34 % | |||
| Shares Owned By Institutions | 90.92 % | |||
| Number Of Shares Shorted | 4.24 M | |||
| Price To Earning | 19.81 X | |||
| Price To Book | 3.92 X | |||
| Price To Sales | 4.35 X | |||
| Revenue | 333.02 M | |||
| Gross Profit | 188.36 M | |||
| EBITDA | 72.02 M | |||
| Net Income | 42.46 M | |||
| Cash And Equivalents | 83.49 M | |||
| Cash Per Share | 1.91 X | |||
| Total Debt | 25 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 3.52 X | |||
| Book Value Per Share | 8.41 X | |||
| Cash Flow From Operations | 82.36 M | |||
| Short Ratio | 7.74 X | |||
| Earnings Per Share | 0.96 X | |||
| Price To Earnings To Growth | 1.33 X | |||
| Target Price | 34.0 | |||
| Number Of Employees | 690 | |||
| Beta | 0.23 | |||
| Market Capitalization | 1.49 B | |||
| Total Asset | 463.1 M | |||
| Retained Earnings | 36.09 M | |||
| Working Capital | 104.22 M | |||
| Current Asset | 126.79 M | |||
| Current Liabilities | 22.57 M | |||
| Z Score | 35.4 | |||
| Five Year Return | 3.78 % | |||
| Net Asset | 463.1 M |
About Meridian Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Meridian Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Meridian Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Meridian Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |